Genome Ventures

Investor type

VC

Founded

2016

AUM

-

Location

Russia

Investment Ticket

$0-1 m

Investment Stage

Seed Series B

Region of investment

Europe
Investor profile last updated: 28 August, 2021

Profile

Genome is an innovative business that changes the game in human capital development.

Since 2016 we focus mainly on EdTech & Smart City Tech.

SmartCity Tech is there to free people up from the mundane, and help them develop their innate abilities and fulfill their dreams. Smart City technologies make transactions and transportation faster, help people customise their environments, and make them more effective. As a result, individuals have more time to focus on themselves, their identity and aspirations.

With EdTech, Genome supports early talent spotting, models professions of the future, builds customized learning products, all to help each and everyone fulfill their potential.

Industry

Edtech SaaS Education Fintech AI MedTech Cybersecurity PropTech / ConTech HealthTech Mobility

Contacts

Name
Title
Email
avatar
Evgenii Buliatkin Investment Analyst
Investment Analyst
-
avatar
Alexander Smbatyan Founder
Founder
-
Upgrade to see contacts
avatar
e9uklK1EpwzmNMfd e9uklK1EpwzmNMfd
e9uklK1EpwzmNMfd
avatar
e9uklK1EpwzmNMfd e9uklK1EpwzmNMfd
e9uklK1EpwzmNMfd
avatar
e9uklK1EpwzmNMfd e9uklK1EpwzmNMfd
e9uklK1EpwzmNMfd
Investment-team contacts for Genome Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Genome Ventures

Genome Ventures is a venture capital firm. It backs companies at Seed and Series B, writing tickets of $0-1 m.
Genome Ventures is located in Russia.
Genome Ventures was founded in 2016.
Genome Ventures invests in companies and startups in Edtech, SaaS, Education, Fintech, AI, MedTech, Cybersecurity, PropTech / ConTech, HealthTech, Mobility.
Genome Ventures invests in companies and startups in Europe.
Genome Ventures invests in companies and startups at Seed, Series B.
Genome Ventures usually invests $0-1 m on average.
Genome Ventures can be reached through its website genomeventures.com and its LinkedIn page. Its general enquiries address is i@genomeventures.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Genome Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Genome Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 28 August, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.